{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T04:32:28Z","timestamp":1791261148684,"version":"4.1.0"},"reference-count":115,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T00:00:00Z","timestamp":1471651200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T00:00:00Z","timestamp":1471651200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100005888","name":"Uniwersytet Medyczny w Lodzi","doi-asserted-by":"crossref","award":["No 503\/8-000-01\/503-81-002"],"award-info":[{"award-number":["No 503\/8-000-01\/503-81-002"]}],"id":[{"id":"10.13039\/501100005888","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Rheumatol Int"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1007\/s00296-016-3555-7","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T06:16:02Z","timestamp":1471673762000},"page":"1481-1491","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":39,"title":["Kaleidoscope of autoimmune diseases in HIV infection"],"prefix":"10.1007","volume":"36","author":[{"given":"Justyna","family":"Roszkiewicz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elzbieta","family":"Smolewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,8,20]]},"reference":[{"key":"3555_CR1","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1016\/j.autrev.2014.04.005","volume":"13","author":"L Iordache","year":"2014","unstructured":"Iordache L, Launay O, Bouchaud O et al (2014) Autoimmune diseases in HIV-infected patients: 52 cases and literature review. Autoimmun Rev 13:850\u2013857","journal-title":"Autoimmun Rev"},{"key":"3555_CR2","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/S1568-9972(02)00086-1","volume":"1","author":"G Zandman-Goddard","year":"2002","unstructured":"Zandman-Goddard G, Shoenfeld Y (2002) HIV and autoimmunity. Autoimmun Rev 1:329\u2013337","journal-title":"Autoimmun Rev"},{"key":"3555_CR3","doi-asserted-by":"publisher","first-page":"19","DOI":"10.7326\/0003-4819-106-1-19","volume":"106","author":"R Winchester","year":"1987","unstructured":"Winchester R, Bernstein DH, Fisher HD et al (1987) The co-occurrence of Reiter\u2019s syndrome and acquired immunodeficiency. Ann Intern Med 106:19\u201326","journal-title":"Ann Intern Med"},{"key":"3555_CR4","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/S0304-3959(96)03215-0","volume":"68","author":"W Breitbart","year":"1996","unstructured":"Breitbart W, McDonald MV, Rosenfeld B et al (1996) Pain in ambulatory AIDS patients. I: pain characteristics and medical correlates. Pain 68:315\u2013321","journal-title":"Pain"},{"key":"3555_CR5","doi-asserted-by":"publisher","first-page":"1607","DOI":"10.1007\/s00296-010-1539-6","volume":"31","author":"Z Romic","year":"2011","unstructured":"Romic Z, Derek L, Burek V et al (2011) Anti-cyclic citrullinated peptide and rheumatoid factor in HIV positive patients. Rheumatol Int 31:1607\u20131610","journal-title":"Rheumatol Int"},{"key":"3555_CR6","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.semarthrit.2005.03.007","volume":"35","author":"LH Calabrese","year":"2005","unstructured":"Calabrese LH, Kirchner E, Shrestha R (2005) Rheumatic complications of human immunodeficiency virus infection in the era of highly active antiretroviral therapy: emergence of a new syndrome of immune reconstitution and changing patterns of disease. Semin Arthritis Rheum 35:166\u2013174","journal-title":"Semin Arthritis Rheum"},{"key":"3555_CR7","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1002\/art.1780331016","volume":"33","author":"JD Reveille","year":"1990","unstructured":"Reveille JD, Conant MA, Duvic M (1990) Human immunodeficiency virus-associated psoriasis, psoriatic arthritis, and Reiter\u2019s syndrome: a disease continuum? Arthritis Rheum 33:1574\u20131578","journal-title":"Arthritis Rheum"},{"key":"3555_CR8","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.berh.2015.04.019","volume":"29","author":"C Fox","year":"2015","unstructured":"Fox C, Walker-Bone K (2015) Evolving spectrum of HIV-associated rheumatic syndromes. Best Pract Res Clin Rheumatol 29:244\u2013258","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"3555_CR9","first-page":"1880","volume":"20","author":"F Medina-Rodriguez","year":"1993","unstructured":"Medina-Rodriguez F, Guzman C, Jara LJ et al (1993) Rheumatic manifestations in human immunodeficiency virus positive and negative individuals: a study of 2 populations with similar risk factors. J Rheumatol 20:1880\u20131884","journal-title":"J Rheumatol"},{"key":"3555_CR10","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/0049-0172(91)90054-4","volume":"21","author":"S Munoz Fernandez","year":"1991","unstructured":"Munoz Fernandez S, Cardenal A, Balsa A et al (1991) Rheumatic manifestations in 556 patients with human immunodeficiency virus infection. Semin Arthritis Rheum 21:30\u201339","journal-title":"Semin Arthritis Rheum"},{"key":"3555_CR11","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1136\/ard.47.4.350-b","volume":"47","author":"J Bijlsma","year":"1988","unstructured":"Bijlsma J, Derksen RW, Huber-Bruning O et al (1988) Does AIDS \u2018cure\u2019 rheumatoid arthritis? Ann Rheum Dis 47:350\u2013351","journal-title":"Ann Rheum Dis"},{"key":"3555_CR12","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1093\/bmb\/lds022","volume":"103","author":"E Lawson","year":"2012","unstructured":"Lawson E, Walker-Bone K (2012) The changing spectrum of rheumatic disease in HIV infection. Br Med Bull 103:203\u2013221","journal-title":"Br Med Bull"},{"key":"3555_CR13","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1038\/ncprheum0836","volume":"4","author":"RM Maganti","year":"2008","unstructured":"Maganti RM, Reveille JD, Williams FM (2008) Therapy insight: the changing spectrum of rheumatic disease in HIV infection. Nat Clin Pract Rheumatol 4:428\u2013438","journal-title":"Nat Clin Pract Rheumatol"},{"key":"3555_CR14","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1016\/j.semarthrit.2014.05.009","volume":"44","author":"GM Mody","year":"2014","unstructured":"Mody GM, Patel N, Budhoo A et al (2014) Concomitant systemic lupus erythematosus and HIV: case series and literature review. Semin Arthritis Rheum 44:186\u2013194","journal-title":"Semin Arthritis Rheum"},{"key":"3555_CR15","doi-asserted-by":"crossref","unstructured":"Maley A, Parker S (2014) Bullous systemic lupus erythematosus in a patient with human immunodeficiency virus infection: a paradox of autoimmunity and immunodeficiency. Dermatol Online J 20(9):pii: 13030\/qt3wv7z5dv","DOI":"10.5070\/D3209023916"},{"key":"3555_CR16","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1191\/0961203302lu141cr","volume":"11","author":"R Palacios","year":"2002","unstructured":"Palacios R, Santos J, Valdivielso P et al (2002) Human immunodeficiency virus infection and systemic lupus erythematosus. An unusual case and a review of the literature. Lupus 11:60\u201363","journal-title":"Lupus"},{"key":"3555_CR17","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1191\/096120300678828136","volume":"9","author":"I Sekigawa","year":"2000","unstructured":"Sekigawa I, Lee S, Kaneko H et al (2000) The possible role of interleukin-16 in the low incidence of HIV infection in patients with systemic lupus erythematosus. Lupus 9:155\u2013156","journal-title":"Lupus"},{"key":"3555_CR18","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1172\/JCI73441","volume":"124","author":"M Bonsignori","year":"2014","unstructured":"Bonsignori M, Wiehe K, Grimm SK et al (2014) An autoreactive antibody from an SLE\/HIV-1 individual broadly neutralizes\u00a0HIV-1. J Clin Invest 124:1835\u20131843","journal-title":"J Clin Invest"},{"key":"3555_CR19","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1586\/14760584.2014.938056","volume":"13","author":"M Bonsignori","year":"2014","unstructured":"Bonsignori M (2014) Will studies in individuals with systemic lupus erythematosus be the key to future HIV vaccine design? Expert Rev Vaccines 13:1271\u20131273","journal-title":"Expert Rev Vaccines"},{"key":"3555_CR20","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/art.1780340318","volume":"34","author":"DJ Wallace","year":"1991","unstructured":"Wallace DJ (1991) Lupus, acquired immunodeficiency syndrome and antimalarial agents. Arthritis Rheum 34:372\u2013373","journal-title":"Arthritis Rheum"},{"key":"3555_CR21","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/s10067-005-1133-6","volume":"25","author":"I Hazarika","year":"2006","unstructured":"Hazarika I, Chakravarty BP, Dutta S et al (2006) Emergence of manifestations of HIV infection in a case of systemic lupus erythematosus following treatment with IV cyclophosphamide. Clin Rheumatol 25:98\u2013100","journal-title":"Clin Rheumatol"},{"key":"3555_CR22","first-page":"510","volume":"18","author":"CM Alonso","year":"2000","unstructured":"Alonso CM, Lozada CJ (2000) Effects of IV cyclophosphamide on HIV viral replication in a patient with systemic lupus erythematosus. Clin Exp Rheumatol 18:510\u2013512","journal-title":"Clin Exp Rheumatol"},{"key":"3555_CR23","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1007\/BF02207681","volume":"14","author":"J Coll","year":"1995","unstructured":"Coll J, Palazon J, Yazbeck H et al (1995) Antibodies to human immunodeficiency virus(HIV-1) in autoimmune diseases: primary Sjogren\u2019s syndrome, systemic lupus erythematosus, rheumatoid arthritis and autoimmune thyroid diseases. Clin Rheumatol 14:451\u2013457","journal-title":"Clin Rheumatol"},{"key":"3555_CR24","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.1093\/rheumatology\/38.10.1017","volume":"38","author":"PR Smith","year":"1999","unstructured":"Smith PR, Cruz D, Raftery MJ et al (1999) Drug-induced lupus nephritis in HIV infection. Rheumatology (Oxford) 38:1017\u20131018","journal-title":"Rheumatology (Oxford)"},{"key":"3555_CR25","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1590\/S0004-27302013000600007","volume":"57","author":"LG Carvalho","year":"2013","unstructured":"Carvalho LG, Teixeira Pde F et al (2013) Evaluation of thyroid function and autoimmunity in HIV-infected women. Arq Bras Endocrinol Metabol 57:450\u2013456","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"3555_CR26","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/01.md.0000159082.45703.90","volume":"84","author":"F Chen","year":"2005","unstructured":"Chen F, Day SL, Metcalfe RA et al (2005) Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease. Medicine (Baltimore) 84:98\u2013106","journal-title":"Medicine (Baltimore)"},{"key":"3555_CR27","first-page":"4254","volume":"85","author":"V Jubault","year":"2000","unstructured":"Jubault V, Penfornis A, Schillo F et al (2000) Sequential occurrence of thyroid autoantibodies and Graves\u2019 disease after immune restoration in severly immunocompromised human immunodeficiency virus-1-infected patients. J Clin Endocrinol Metab 85:4254\u20134257","journal-title":"J Clin Endocrinol Metab"},{"key":"3555_CR28","doi-asserted-by":"publisher","first-page":"743597","DOI":"10.1155\/2011\/743597","volume":"2011","author":"S Rasul","year":"2011","unstructured":"Rasul S, Delapenha R, Farhat F et al (2011) Graves\u2019 disease as a manifestation of immune reconstitution in HIV-infected individuals after initiation of highly active antiretroviral therapy. AIDS Res Treat 2011:743597. doi:10.1155\/2011\/743597","journal-title":"AIDS Res Treat"},{"key":"3555_CR29","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1038\/25374","volume":"396","author":"D Douek","year":"1998","unstructured":"Douek D, McFarland R, Keiser P et al (1998) Changes in thymic function with age and during the treatment of HIV infection. Nature 396:690\u2013694","journal-title":"Nature"},{"key":"3555_CR30","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1089\/088922204773004879","volume":"20","author":"MA French","year":"2004","unstructured":"French MA, Lewin SR, Dykstra C et al (2004) Graves\u2019 disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: evidence of thymic dysfunction. AIDS Res Hum Retroviruses 20:157\u2013162","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3555_CR31","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.beem.2009.07.003","volume":"23","author":"A Weetman","year":"2009","unstructured":"Weetman A (2009) Immune reconstitution syndrome and the thyroid. Best Pract Res Clin Endocrinol Metab 23:693\u2013702","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"3555_CR32","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1089\/vim.2006.19.102","volume":"19","author":"B Knysz","year":"2006","unstructured":"Knysz B, Bolanowski M, Klimczak M et al (2006) Graves\u2019 disease as an immune reconstitution syndrome in an HIV-1-positive patient commencing effective antiretroviral therapy: case report and literature review. Viral Immunol 19:102\u2013107","journal-title":"Viral Immunol"},{"key":"3555_CR33","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1089\/thy.2004.14.1097","volume":"14","author":"C Jimenez","year":"2004","unstructured":"Jimenez C, Moran SA, Sereti I et al (2004) Graves\u2019 disease after interleukin-2 therapy in a patient with human immunodeficiency virus infection. Thyroid 14:1097\u20131102","journal-title":"Thyroid"},{"key":"3555_CR34","doi-asserted-by":"publisher","first-page":"853","DOI":"10.1089\/thy.2012.0055","volume":"22","author":"R Visser","year":"2012","unstructured":"Visser R, de Mast Q, Netea-Maier RT et al (2012) Hashimoto\u2019s thyroiditis presenting as acute painful thyroiditis and as a manifestation of autoimmune reconstitution inflammatory syndrome in a human immunodeficiency virus- seropositive patient. Thyroid 22:853\u2013855","journal-title":"Thyroid"},{"key":"3555_CR35","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.1365-2265.2006.02472.x","volume":"64","author":"G Madeddu","year":"2006","unstructured":"Madeddu G, Spanu A, Chessa F et al (2006) Thyroid function in human immunodeficiency virus patients treated with highly active antiretroviral therapy (HAART): a longitudinal study. Clin Endocrinol (Oxford) 64:375\u2013383","journal-title":"Clin Endocrinol (Oxford)"},{"key":"3555_CR36","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1097\/QAI.0b013e31818ce835","volume":"50","author":"M Nelson","year":"2009","unstructured":"Nelson M, Powles T, Zeitlin A et al (2009) Thyroid dysfunction and relationship to antiretroviral therapy in HIV-positive individuals in the HAART era. J Acquir Immune Defic Syndr 50:113\u2013114","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3555_CR37","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1590\/2359-3997000000023","volume":"59","author":"GA Silva","year":"2015","unstructured":"Silva GA, Andrade MC, Sugui DA et al (2015) Association between antiretrovirals and thyroid diseases: a cross-sectional study. Arch Endocrinol Metab 59:116\u2013122","journal-title":"Arch Endocrinol Metab"},{"key":"3555_CR38","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1136\/pmj.79.935.535","volume":"79","author":"M Trevenzoli","year":"2003","unstructured":"Trevenzoli M, Cattelan AM, Marino F et al (2003) Sarcoidosis and HIV infection: a case report and a review of the literature. Postgrad Med J 79:535\u2013538","journal-title":"Postgrad Med J"},{"key":"3555_CR39","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1378\/chest.96.1.201","volume":"96","author":"LE Coots","year":"1989","unstructured":"Coots LE, Lazarus AA (1989) Sarcoidosis diagnosed in a patient with known HIV infection. Chest 96:201\u2013202","journal-title":"Chest"},{"key":"3555_CR40","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1001\/jama.280.1.72","volume":"280","author":"WG Powderly","year":"1998","unstructured":"Powderly WG, Landay A, Lederman MM (1998) Recovery of the immune system with antiretroviral therapy: the end of opportunism? JAMA 280:72\u201377","journal-title":"JAMA"},{"key":"3555_CR41","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1513\/pats.200606-130MS","volume":"4","author":"J Grunewald","year":"2007","unstructured":"Grunewald J, Eklund A (2007) Role of CD4+ T cells in sarcoidosis. Proc Am Thorac Soc 4:461\u2013464","journal-title":"Proc Am Thorac Soc"},{"key":"3555_CR42","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1086\/381094","volume":"38","author":"G Foulon","year":"2004","unstructured":"Foulon G, Wislez M, Naccache JM et al (2004) Sarcoidosis in HIV- infected patients in the era of highly active antiretroviral therapy. Clin Infect Dis 38:418\u2013425","journal-title":"Clin Infect Dis"},{"key":"3555_CR43","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1086\/317475","volume":"31","author":"P Blanche","year":"2000","unstructured":"Blanche P, Gombert B, Rollot F et al (2000) Sarcoidosis in a patient with acquired immunodeficiency treated with interleukin-2. Clin Infectious Dis 31:1493\u20131494","journal-title":"Clin Infectious Dis"},{"key":"3555_CR44","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jinf.2005.05.009","volume":"52","author":"F Almeida","year":"2006","unstructured":"Almeida F, Sager J, Eiger G (2006) Coexistent sarcoidosis and HIV infection: an immunological paradox? J Infect 52:195\u2013201","journal-title":"J Infect"},{"key":"3555_CR45","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1258\/ijsa.2011.011044","volume":"23","author":"VA Fernandez","year":"2012","unstructured":"Fernandez VA, Thomas DB, Reiser IW et al (2012) Immune reconstitution renal-limited sarcoidosis presenting as acute kidney injury. Int J STD AIDS 23:68\u201370","journal-title":"Int J STD AIDS"},{"key":"3555_CR46","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.autrev.2014.04.001","volume":"13","author":"Y Jamilloux","year":"2014","unstructured":"Jamilloux Y, Kodjikian L, Broussolle C et al (2014) Sarcoidosis and uveitis. Autoimmun Rev 13:840\u2013849","journal-title":"Autoimmun Rev"},{"key":"3555_CR47","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1148\/radiology.218.1.r01ja25242","volume":"218","author":"L Haramati","year":"2001","unstructured":"Haramati L, Godwin L, Singh A et al (2001) Newly diagnosed pulmonary sarcoidosis in HIV-infected patients. Radiology 218:242\u2013246","journal-title":"Radiology"},{"key":"3555_CR48","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.cgh.2009.09.025","volume":"8","author":"N Crum-Cianflone","year":"2010","unstructured":"Crum-Cianflone N, Collins G, Medina S et al (2010) Prevalence and factors associated with liver test abnormalities among human immunodeficiency virus-infected persons. Clin Gastroenterol Hepatol 8:183\u2013191","journal-title":"Clin Gastroenterol Hepatol"},{"key":"3555_CR49","doi-asserted-by":"publisher","first-page":"e4517","DOI":"10.1371\/journal.pone.0004517","volume":"4","author":"EE Moodie","year":"2009","unstructured":"Moodie EE, Pant Pai N et al (2009) Is antiretroviral therapy causing long-term liver damage? A comparative analysis of HIV mono- infected and HIV\/hepatitis C co-infected cohorts. PLoS ONE 4:e4517","journal-title":"PLoS ONE"},{"key":"3555_CR50","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1080\/00365529850166284","volume":"33","author":"K Boberg","year":"1998","unstructured":"Boberg K, Aadland E, Jahnsen J et al (1998) Incidence and prevalence of primary biliary cirrhosis, primary sclerosing cholangitis, and autoimmune hepatitis in a Norwegian population. Scand J Gastroenterol 33:99\u2013103","journal-title":"Scand J Gastroenterol"},{"key":"3555_CR51","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1097\/01.mcg.0000225591.08825.3e","volume":"4","author":"Y Puius","year":"2008","unstructured":"Puius Y, Dove L, Brust D et al (2008) Three cases of autoimmune hepatitis in HIV-infected patients. J Clin Gastroenterol 4:425\u2013429","journal-title":"J Clin Gastroenterol"},{"key":"3555_CR52","doi-asserted-by":"crossref","first-page":"270","DOI":"10.5455\/jihp.20130624104921","volume":"1","author":"M Caplan","year":"2013","unstructured":"Caplan M, Trivedi A, McLaughlin M et al (2013) Primary biliary cirrhosis overlapping with autoimmune hepatitis in an HIV-infected patient on antiretroviral therapy. J Interdiscip Histopathol 1:270\u2013273","journal-title":"J Interdiscip Histopathol"},{"key":"3555_CR53","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1258\/ijsa.2009.009337","volume":"23","author":"S Hagel","year":"2012","unstructured":"Hagel S, Bruns T, Herrmann A et al (2012) Autoimmune hepatitis in an HIV-infected patient: an intriguing association. Int J STD AIDS 23:448\u2013450","journal-title":"Int J STD AIDS"},{"key":"3555_CR54","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1155\/2014\/373898","volume":"25","author":"C Tan-Tam","year":"2014","unstructured":"Tan-Tam C, Liao P, Montaner JS et al (2014) HIV and liver transplantation: the British Columbia experience 2004 to 2013. Can J Infect Dis Med Microbiol 25:159\u2013162","journal-title":"Can J Infect Dis Med Microbiol"},{"key":"3555_CR55","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1258\/ijsa.2007.007185","volume":"19","author":"R Coriat","year":"2008","unstructured":"Coriat R, Podevin P (2008) Fulminant autoimmune hepatitis after successful interferon treatment in an HIV\u2013HCV co-infected patient. Int J STD AIDS 19:208\u2013210","journal-title":"Int J STD AIDS"},{"key":"3555_CR56","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1086\/524082","volume":"46","author":"JG O\u2019Leary","year":"2008","unstructured":"O\u2019Leary JG, Zachary K, Misdraji J et al (2008) De novo autoimmune hepatitis during immune reconstitution in an HIV-infected patient receiving highly active antiretroviral therapy. Clin Infect Dis 46:e12\u2013e14","journal-title":"Clin Infect Dis"},{"key":"3555_CR57","doi-asserted-by":"publisher","first-page":"223","DOI":"10.2169\/internalmedicine.54.3094","volume":"54","author":"Y Kaku","year":"2015","unstructured":"Kaku Y, Kodama S, Higuchi M et al (2015) Corticoid therapy for overlapping syndromes in an HIV-positive patient. Intern Med 54:223\u2013230","journal-title":"Intern Med"},{"key":"3555_CR58","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1093\/jac\/dkn416","volume":"62","author":"E Vispo","year":"2008","unstructured":"Vispo E, Maida I, Moreno A et al (2008) Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C. J Antimicrob Chemother 62:1470\u20131472","journal-title":"J Antimicrob Chemother"},{"key":"3555_CR59","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1080\/00365540510026841","volume":"37","author":"V German","year":"2005","unstructured":"German V, Vassiloyanakopoulos A, Sampaziotis D et al (2005) Autoimmune hepatitis in an HIV infected patient that responded to antiretroviral therapy. Scand J Infect Dis 37:148\u2013151","journal-title":"Scand J Infect Dis"},{"key":"3555_CR60","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1016\/j.imlet.2005.02.018","volume":"99","author":"D Stahl","year":"2005","unstructured":"Stahl D, Lacroix-Desmazes S, Misra N et al (2005) Alterations of self-reactive antibody repertoires in HIV disease: an insight into the role of T cells in the selection of autoreactive B cells. Immunol Lett 99:198\u2013208","journal-title":"Immunol Lett"},{"key":"3555_CR61","doi-asserted-by":"publisher","first-page":"929","DOI":"10.1016\/S0168-8278(99)80297-9","volume":"31","author":"F Alvarez","year":"1999","unstructured":"Alvarez F, Berg PA, Bianchi FB et al (1999) International autoimmune hepatitis group report: review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 31:929\u2013938","journal-title":"J Hepatol"},{"key":"3555_CR62","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJM199604043341406","volume":"334","author":"EL Krawitt","year":"1996","unstructured":"Krawitt EL (1996) Autoimmune hepatitis. N Engl J Med 334:897\u2013903","journal-title":"N Engl J Med"},{"key":"3555_CR63","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1016\/0016-5085(95)90139-6","volume":"108","author":"L Garcia-Buey","year":"1995","unstructured":"Garcia-Buey L, Garcia-Monzon C, Rodriguez S et al (1995) Latent autoimmune hepatitis triggered during interferon therapy in patients with chronic hepatitis C. Gastroenterology 108:1770\u20131777","journal-title":"Gastroenterology"},{"issue":"3","key":"3555_CR64","first-page":"613","volume":"21","author":"BD Clifford","year":"1995","unstructured":"Clifford BD, Donahue D, Smith L et al (1995) High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21(3):613\u2013619","journal-title":"Hepatology"},{"key":"3555_CR65","doi-asserted-by":"publisher","first-page":"51","DOI":"10.7326\/0003-4819-116-1-51","volume":"116","author":"T Papo","year":"1992","unstructured":"Papo T, Marcellin P, Bernuau J et al. (1992) Autoimmune chronic hepatitis exacerbated by alpha-interferon. Ann Intern Med 116:51\u201353","journal-title":"Ann Intern Med"},{"key":"3555_CR66","first-page":"1575","volume":"78","author":"C Trepo","year":"1970","unstructured":"Trepo C, Thivolet J (1970) Australia antigen, virus hepatitis and periarteritis nodosa. Presse Med 78:1575","journal-title":"Presse Med"},{"key":"3555_CR67","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1080\/08916930310001602137","volume":"36","author":"B Conrad","year":"2003","unstructured":"Conrad B (2003) Potential mechanisms of interferon-alpha induced autoimmunity. Autoimmunity 36:519\u2013523","journal-title":"Autoimmunity"},{"key":"3555_CR68","doi-asserted-by":"publisher","first-page":"e0152316","DOI":"10.1371\/journal.pone.0152316","volume":"11","author":"EP Browne","year":"2016","unstructured":"Browne EP, Letham B, Rudin C (2016) A computational model of inhibition of HIV-1 by interferon-alpha. PLoS ONE 11:e0152316","journal-title":"PLoS ONE"},{"key":"3555_CR69","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1056\/NEJM199211193272104","volume":"327","author":"V Agnello","year":"1992","unstructured":"Agnello V, Chung RT, Kaplan LE (1992) A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 327:1490\u20131495","journal-title":"N Engl J Med"},{"key":"3555_CR70","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/BF02771754","volume":"14","author":"B Kaye","year":"1996","unstructured":"Kaye B (1996) Rheumatologic manifestations of HIV infections. Clin Rev Allergy Immunol 14:385\u2013416","journal-title":"Clin Rev Allergy Immunol"},{"key":"3555_CR71","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1002\/1529-0131(200012)13:6<424::AID-ART14>3.0.CO;2-Q","volume":"13","author":"JH Stone","year":"2000","unstructured":"Stone JH, Talor M, Stebbing J et al (2000) Test characteristics of immunofluorescence and ELISA tests in 856 consecutive patients with possible ANCA-associated conditions. Arthritis Care Res 13:424\u2013434","journal-title":"Arthritis Care Res"},{"key":"3555_CR72","first-page":"685","volume":"321","author":"R Gherardi","year":"1989","unstructured":"Gherardi R, Lebargy F, Gaulard P et al (1989) Necrotizing vasculitis and HIV replication in peripheral nerves. N Engl J Med 321:685\u2013686","journal-title":"N Engl J Med"},{"key":"3555_CR73","doi-asserted-by":"publisher","first-page":"886","DOI":"10.1212\/WNL.38.6.886","volume":"38","author":"RO Bailey","year":"1988","unstructured":"Bailey RO, Baltch AL, VenKatesh R et al (1988) Sensory motor neuropathy associated with AIDS. Neurology 38:886\u2013889","journal-title":"Neurology"},{"key":"3555_CR74","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1097\/01.aids.0000218551.62210.b5","volume":"20","author":"D Saadoun","year":"2006","unstructured":"Saadoun D, Aaron L, Resche-Rigon M et al (2006) Cryoglobulinemia vasculitis in patients co-infected with HIV and hepatitis C virus. AIDS 20:871\u2013877","journal-title":"AIDS"},{"key":"3555_CR75","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00002281-199801000-00008","volume":"10","author":"BF Mandell","year":"1998","unstructured":"Mandell BF, Calabrese LH (1998) Infectious and systemic vasculitides. Curr Opin Rheumatol 10:51\u201357","journal-title":"Curr Opin Rheumatol"},{"key":"3555_CR76","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1093\/rheumatology\/35.8.796","volume":"35","author":"C Font","year":"1996","unstructured":"Font C, Miro O, Pedrol E et al (1996) Polyarteritis nodosa in human immunodeficiency virus infection: report of four cases and review of the literature. Br J Rheumatol 35:796\u2013799","journal-title":"Br J Rheumatol"},{"issue":"Suppl. 1","key":"3555_CR77","doi-asserted-by":"publisher","first-page":"S77","DOI":"10.1097\/00002030-200304001-00011","volume":"17","author":"RM Johnson","year":"2003","unstructured":"Johnson RM, Barbarini G, Barbaro G (2003) Kawasaki-like syndromes and other vasculitic syndromes in HIV-infected patients. AIDS 17(Suppl. 1):S77\u2013S82","journal-title":"AIDS"},{"key":"3555_CR78","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1097\/01.aids.0000327513.53255.17","volume":"22","author":"L Guillevin","year":"2008","unstructured":"Guillevin L (2008) Vasculitidies in the context of HIV infection. AIDS 22:S27\u2013S33","journal-title":"AIDS"},{"key":"3555_CR79","first-page":"464","volume":"16","author":"AP Velez","year":"2006","unstructured":"Velez AP, Menezez L, Crespo A (2006) Kawasaki-like syndrome possibly associated with immune reconstitution inflammatory syndrome in an HIV-positive patient. AIDS Read 16:464\u2013466","journal-title":"AIDS Read"},{"key":"3555_CR80","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/QAI.0000000000000478","volume":"68","author":"NT Funderburg","year":"2015","unstructured":"Funderburg NT, Jiang Y, Debanne SM et al (2015) Rosuvastatin reduces vascular inflammation and T-cell and monocyte activation in HIV-infected subjects on antiretroviral therapy. J Acquir Immune Defic Syndr 68:396\u2013404","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3555_CR81","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1136\/jcp.54.4.275","volume":"54","author":"R Chetty","year":"2001","unstructured":"Chetty R (2001) Vasculitides associated with HIV infection. J Clin Pathol 54:275\u2013278","journal-title":"J Clin Pathol"},{"key":"3555_CR82","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1007\/s11926-011-0214-6","volume":"13","author":"N Patel","year":"2011","unstructured":"Patel N, Patel N, Khan T et al (2011) HIV infection and clinical spectrum of associated vasculitides. Curr Rheumatol Rep 13:506\u2013512","journal-title":"Curr Rheumatol Rep"},{"key":"3555_CR83","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1177\/1076029607310217","volume":"15","author":"G de Larranaga","year":"2009","unstructured":"de Larranaga G, Bottaro E, Martinuzzo M et al (2009) Thrombophilia in human immunodeficiency virus-infected patients with osteonecrosis: is there a real connection? The first case-control study. Clin Appl Thromb Hemost 15:340\u2013347","journal-title":"Clin Appl Thromb Hemost"},{"key":"3555_CR84","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1111\/j.1538-7836.2006.02047.x","volume":"4","author":"WM Lijfering","year":"2006","unstructured":"Lijfering WM, Ten Kate MK, Sprenger HG et al (2006) Absolute risk of venous and arterial thrombosis in HIV infected patients and effects of combination antiretroviral therapy. J Thromb Haemost 4:1928\u20131930","journal-title":"J Thromb Haemost"},{"key":"3555_CR85","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1089\/aid.2005.21.753","volume":"21","author":"MS Dillmon","year":"2005","unstructured":"Dillmon MS, Saag MS, Hamza SH et al (2005) Unusual thromboses associated with protein S deficiency in patients with acquired immunodeficiency syndrome: case reports and review of the literature. AIDS Res Hum Retroviruses 21:753\u2013756","journal-title":"AIDS Res Hum Retroviruses"},{"key":"3555_CR86","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1007\/s10067-007-0581-6","volume":"26","author":"L Galr\u00e3o","year":"2007","unstructured":"Galr\u00e3o L, Brites C, Atta ML et al (2007) Antiphospholipid antibodies in HIV-positive patients. Clin Rheumatol 26:1825\u20131830","journal-title":"Clin Rheumatol"},{"key":"3555_CR87","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1053\/sarh.2002.28303","volume":"31","author":"IW Uthman","year":"2002","unstructured":"Uthman IW, Gharavi AE (2002) Viral infections and antiphospholipid antibodies. Semin Arthritis Rheum 31:256\u2013263","journal-title":"Semin Arthritis Rheum"},{"key":"3555_CR88","first-page":"238","volume":"27","author":"J Rojas-Rodriguez","year":"2000","unstructured":"Rojas-Rodriguez J, Garcia-Carrasco M, Ramos-Casals M et al (2000) Catastrophic antiphospholipid syndrome: clinical description and triggering factors in 8 patients. J Rheumatol 27:238\u2013240","journal-title":"J Rheumatol"},{"key":"3555_CR89","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1097\/00005792-200111000-00002","volume":"80","author":"RA Asherson","year":"2001","unstructured":"Asherson RA, Cervera R, Piette JC et al (2001) Catastrophic antiphospholipid syndrome: clues to the pathogenesis from a series of 80 patients. Medicine (Baltimore) 80:355\u2013737","journal-title":"Medicine (Baltimore)"},{"key":"3555_CR90","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1086\/382537","volume":"38","author":"M Ramos-Casals","year":"2004","unstructured":"Ramos-Casals M, Cervera R, Lagrutta M et al (2004) Hispanoamerican study group of autoimmune manifestations of chronic viral disease (HISPAMEC). Clinical features related to antiphospholipid syndrome in patients with chronic viral infections (hepatitis C virus\/HIV infection): description of 82 cases. Clin Infect Dis 38:1009\u20131016","journal-title":"Clin Infect Dis"},{"key":"3555_CR91","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1006\/jaut.1999.0324","volume":"13","author":"C Petrovas","year":"1999","unstructured":"Petrovas C, Vlachoyiannopoulos PG, Kordossis T et al (1999) Antiphospholipid antibodies in HIV infection and SLE with or without antiphospholipid syndrome: comparisons of phospholipid specificity, avidity and reactivity with beta2-GPI. J Autoimmune 13:347\u2013355","journal-title":"J Autoimmune"},{"key":"3555_CR92","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1001\/archinte.1989.00390080091020","volume":"149","author":"MM Stimmler","year":"1989","unstructured":"Stimmler MM, Quismorio FP, McGehee QG et al (1989) Anticardiolipin antibodies in acquired immunodeficiency syndrome. Arch Intern Med 149:1833\u20131835","journal-title":"Arch Intern Med"},{"key":"3555_CR93","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00296-011-1859-1","volume":"32","author":"A Abdollahi","year":"2012","unstructured":"Abdollahi A, Morteza A (2012) Serum concentrations of antiphospholipid and anticardiolipin antibodies are higher in HIV-infected women. Rheumatol Int 32:1927\u20131932","journal-title":"Rheumatol Int"},{"key":"3555_CR94","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1191\/096120301669209574","volume":"10","author":"AN Leder","year":"2001","unstructured":"Leder AN, Flansbaum B, Zandman-Goddard G et al (2001) Antiphospholipid syndrome induced by HIV. Lupus 10:370\u2013374","journal-title":"Lupus"},{"key":"3555_CR95","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1055\/s-0038-1656067","volume":"77","author":"N Abuaf","year":"1997","unstructured":"Abuaf N, Laperche S, Rajoaely B et al (1997) Autoantibodies to phospholipids and to the coagulation proteins in AIDS. Thromb Haemost 77:856","journal-title":"Thromb Haemost"},{"key":"3555_CR96","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1172\/JCI0212337","volume":"109","author":"M Blank","year":"2002","unstructured":"Blank M, Krause I, Fridkin M et al (2002) Bacterial induction of autoantibodies to beta2-glycoprotein-I accounting for infectious etiology if antiphospholipid syndrome. J Clin Invest 109:797\u2013804","journal-title":"J Clin Invest"},{"key":"3555_CR97","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1136\/ard.62.5.388","volume":"62","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Cervera R (2003) Antiphospholipid antibodies and infections. Ann Rheum Dis 62:388\u2013393","journal-title":"Ann Rheum Dis"},{"key":"3555_CR98","first-page":"214","volume":"30","author":"RA Asherson","year":"2003","unstructured":"Asherson RA, Shoenfeld Y (2003) Human immunodeficiency virus infection, antiphospholipid antibodies, and the antiphospholipid syndrome. J Rheumatol 30:214\u2013219","journal-title":"J Rheumatol"},{"key":"3555_CR99","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1111\/j.1365-2141.1992.tb06476.x","volume":"82","author":"GH Mientjes","year":"1992","unstructured":"Mientjes GH, Van Ameijden EJ, Mulder J et al (1992) Prevalence of thrombocytopenia in HIV-infected and non- HIV infected drug users and homosexual men. Br J Haematol 82:615\u2013619","journal-title":"Br J Haematol"},{"key":"3555_CR100","doi-asserted-by":"publisher","first-page":"910954","DOI":"10.1155\/2012\/910954","volume":"2012","author":"KL Ambler","year":"2012","unstructured":"Ambler KL, Vickars LM, Leger CS et al (2012) Clinical features, treatment, and outcome of HIV-associated immune thrombocytopenia in the HAART era. Adv Hematol 2012:910954. doi:10.1155\/2012\/910954","journal-title":"Adv Hematol"},{"key":"3555_CR101","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1111\/j.1600-0609.1992.tb00591.x","volume":"48","author":"EM Sloand","year":"1992","unstructured":"Sloand EM, Klein HG, Banks SM et al (1992) Epidemiology of thrombocytopenia in HIV infection. Eur J Haematol 48:168\u2013172","journal-title":"Eur J Haematol"},{"key":"3555_CR102","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1097\/00042560-200111010-00003","volume":"28","author":"J Servais","year":"2001","unstructured":"Servais J, Nkoghe D, Schmit J et al (2001) HIV-associated hematologic disorders are correlated with plasma viral load and improve under highly active antiretroviral therapy. J Acquir Immune Defic Syndr 28:221\u2013225","journal-title":"J Acquir Immune Defic Syndr"},{"key":"3555_CR103","doi-asserted-by":"publisher","first-page":"474","DOI":"10.7326\/0003-4819-107-4-474","volume":"4","author":"RA Kaslow","year":"1987","unstructured":"Kaslow RA, Phair JP, Friedman HB et al (1987) Infection with human immunodeficiency virus: clinical manifestations and their relationship to immune deficiency. A report from the multicenter acquired immune deficiency syndrome cohort study. Ann Intern Med 4:474\u2013480","journal-title":"Ann Intern Med"},{"key":"3555_CR104","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1182\/blood.V80.1.162.162","volume":"80","author":"A Bettaieb","year":"1992","unstructured":"Bettaieb A, Fromont P, Louache F et al (1992) Presence of cross-reactive antibody between human immunodeficiency virus (HIV) and platelet glycoproteins in HIV-related immune thrombocytopenic purpura. Blood 80:162\u2013169","journal-title":"Blood"},{"key":"3555_CR105","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.ijid.2008.05.1225","volume":"13","author":"T Bunupuradah","year":"2009","unstructured":"Bunupuradah T, Puthanakit T, Pancharoen C et al (2009) Henoch\u2013Schonlein purpura and thrombocytopenia after planned antiretroviral treatment interruption in a Thai girl with HIV infection. Int J Infect Dis 13:31\u201333","journal-title":"Int J Infect Dis"},{"key":"3555_CR106","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1172\/JCI115593","volume":"89","author":"S Karpatkin","year":"1992","unstructured":"Karpatkin S, Nardi M (1992) Autoimmune anti-HIV-1gp120 antibody with antiidiotype-like activity in sera and immune complexes of HIV-1-related immunologic thrombocytopenia. J Clin Invest 89:356\u2013364","journal-title":"J Clin Invest"},{"key":"3555_CR107","doi-asserted-by":"publisher","first-page":"9763","DOI":"10.1073\/pnas.85.24.9763","volume":"85","author":"S Karpatkin","year":"1988","unstructured":"Karpatkin S, Nardi M, Lennette ET et al (1988) Anti-human immunodeficiency virus type 1 antibody complexes on platelets of seropositive thrombocytopenic homosexuals and narcotic addicts. Proc Natl Acad Sci USA 85:9763\u20139767","journal-title":"Proc Natl Acad Sci USA"},{"key":"3555_CR108","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1258\/ijsa.2011.011028","volume":"23","author":"M Wood","year":"2012","unstructured":"Wood M, Bradley M (2012) An unusual haematological presentation of the immune reconstitution inflammatory syndrome. Int J STD AIDS 23:147\u2013148","journal-title":"Int J STD AIDS"},{"key":"3555_CR109","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1097\/00002030-199001000-00004","volume":"4","author":"G Landonio","year":"1990","unstructured":"Landonio G, Galli M, Nosari A et al (1990) HIV-related severe thrombocytopenia in intravenous drug users: prevalence, response to therapy in a medium-term follow-up, and pathogenetic evaluation. AIDS 4:29\u201334","journal-title":"AIDS"},{"key":"3555_CR110","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1097\/00002030-199111000-00012","volume":"5","author":"MU Rarick","year":"1991","unstructured":"Rarick MU, Espina B, Montgomery T et al (1991) The long-term use of zidovudine in patients with severe immune-mediated thrombocytopenia secondary to infection with HIV. AIDS 5:1357\u20131361","journal-title":"AIDS"},{"key":"3555_CR111","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1097\/00000441-200008000-00010","volume":"320","author":"DM Aboulafia","year":"2000","unstructured":"Aboulafia DM, Bundow D, Waide S et al (2000) Initial observations on the efficacy of highly active antiretroviral therapy in the treatment of HIV-associated autoimmune thrombocytopenia. Am J Med Sci 320:117\u2013123","journal-title":"Am J Med Sci"},{"key":"3555_CR112","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1007\/s00277-009-0744-4","volume":"88","author":"S Hewamana","year":"2009","unstructured":"Hewamana S, Pepper C, Karunanithi K et al (2009) Durable response to a single dose of anti D in immune thrombocytopenic purpura in an adult with underlying human immunodeficiency viral infection. Ann Hematol 88:1155\u20131156","journal-title":"Ann Hematol"},{"key":"3555_CR113","doi-asserted-by":"publisher","first-page":"408","DOI":"10.7196\/SAMJ.8987","volume":"105","author":"KR Antel","year":"2015","unstructured":"Antel KR, Panieri E, Novitzky N (2015) Role of splenectomy for immune thrombocytopenic purpura (ITP) in the era of new second-line therapies and in the setting of a high prevalence of HIV-associated ITP. S Afr Med J 105:408\u2013412","journal-title":"S Afr Med J"},{"key":"3555_CR114","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1007\/s10096-007-0360-y","volume":"26","author":"P Morelli","year":"2007","unstructured":"Morelli P, Besetti G, longhi E (2007) Persistent parvovirus B19-induced anemia in an HIV-infected patient under HAART. Case report and review of literature. Eur J Clin Microbiol Infect Dis 26:833\u2013837","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"3555_CR115","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/1596-3519.55677","volume":"7","author":"E Olayemi","year":"2008","unstructured":"Olayemi E, Awodu OA, Bazuaye GN (2008) Autoimmune hemolitic anemia in HIV-infected patients: A hospital based study. Annals African Med 7:72\u201376","journal-title":"Annals African Med"}],"container-title":["Rheumatology International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3555-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00296-016-3555-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00296-016-3555-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T00:02:32Z","timestamp":1718755352000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00296-016-3555-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,20]]},"references-count":115,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["3555"],"URL":"https:\/\/doi.org\/10.1007\/s00296-016-3555-7","relation":{},"ISSN":["0172-8172","1437-160X"],"issn-type":[{"value":"0172-8172","type":"print"},{"value":"1437-160X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,20]]},"assertion":[{"value":"1 June 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 August 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}